Biogen(BIIB) - 2025 Q1 - Quarterly Results

Press Release Cambridge, Mass. – May 1, 2025 Biogen reports strong first quarter 2025 results First quarter 2025 total revenue $2.4 billion, increased 6% year-over-year; GAAP diluted EPS$ 1.64; Non-GAAP diluted EPS $3.02 Continued progress transforming the commercial portfolio, with growth from launch products in Alzheimer's disease, rare disease, and postpartum depression more than doubling year-over-year Advanced key development programs, supporting a late-stage pipeline with multi-billion dollar potentia ...